Gregory Fraser
Stock Analyst at Truist Securities
(2.65)
# 2,137
Out of 4,915 analysts
36
Total ratings
53.85%
Success rate
16.21%
Average return
Main Sectors:
Stocks Rated by Gregory Fraser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANIP ANI Pharmaceuticals | Maintains: Hold | $62 → $65 | $64.34 | +1.03% | 9 | Apr 21, 2025 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $220 → $230 | $114.63 | +100.65% | 1 | Mar 6, 2025 | |
| BHC Bausch Health Companies | Maintains: Hold | $8 → $7 | $5.89 | +18.85% | 2 | Jul 25, 2024 | |
| XAIR Beyond Air | Maintains: Buy | $200 → $160 | $2.98 | +5,269.13% | 6 | Apr 30, 2024 | |
| BTMD biote | Maintains: Buy | $10 → $9 | $4.07 | +121.13% | 2 | Jan 18, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6 → $7 | $7.82 | -10.49% | 4 | Nov 8, 2023 | |
| CORT Corcept Therapeutics | Maintains: Hold | $26 → $29 | $67.17 | -56.83% | 5 | Aug 3, 2023 | |
| NVCR NovoCure | Reiterates: Buy | $95 | $11.57 | +721.09% | 3 | Jun 6, 2023 | |
| EOLS Evolus | Maintains: Buy | $14 → $18 | $8.92 | +101.79% | 2 | May 26, 2023 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $45 → $40 | $14.58 | +174.35% | 2 | May 26, 2023 |
ANI Pharmaceuticals
Apr 21, 2025
Maintains: Hold
Price Target: $62 → $65
Current: $64.34
Upside: +1.03%
Jazz Pharmaceuticals
Mar 6, 2025
Maintains: Buy
Price Target: $220 → $230
Current: $114.63
Upside: +100.65%
Bausch Health Companies
Jul 25, 2024
Maintains: Hold
Price Target: $8 → $7
Current: $5.89
Upside: +18.85%
Beyond Air
Apr 30, 2024
Maintains: Buy
Price Target: $200 → $160
Current: $2.98
Upside: +5,269.13%
biote
Jan 18, 2024
Maintains: Buy
Price Target: $10 → $9
Current: $4.07
Upside: +121.13%
Amneal Pharmaceuticals
Nov 8, 2023
Maintains: Buy
Price Target: $6 → $7
Current: $7.82
Upside: -10.49%
Corcept Therapeutics
Aug 3, 2023
Maintains: Hold
Price Target: $26 → $29
Current: $67.17
Upside: -56.83%
NovoCure
Jun 6, 2023
Reiterates: Buy
Price Target: $95
Current: $11.57
Upside: +721.09%
Evolus
May 26, 2023
Maintains: Buy
Price Target: $14 → $18
Current: $8.92
Upside: +101.79%
Arcutis Biotherapeutics
May 26, 2023
Maintains: Buy
Price Target: $45 → $40
Current: $14.58
Upside: +174.35%